Detalles de la búsqueda
1.
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Stroke;
54(3): 697-705, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36734235
2.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
N Engl J Med;
380(20): 1906-1917, 2019 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31091372
3.
Bridging Therapy With Heparin Before Starting Rivaroxaban in Ischemic Stroke or Transient Ischemic Attack With Non-Valvular Atrial Fibrillation.
Circ J;
86(6): 958-963, 2022 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789635
4.
Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.
Stroke;
52(4): 1234-1243, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563017
5.
Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.
Stroke;
52(3): 1069-1073, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588594
6.
Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Stroke;
52(11): 3430-3439, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34404237
7.
Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
N Engl J Med;
378(23): 2182-2190, 2018 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29766771
8.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
N Engl J Med;
378(23): 2191-2201, 2018 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29766772
9.
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials.
BMC Med Res Methodol;
21(1): 218, 2021 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657596
10.
Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study.
Heart Vessels;
36(9): 1410-1420, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33728513
11.
ASPECTS-Region-Dependent Functional Outcomes after Endovascular Therapy in Patients with Cardioembolic Stroke.
J Stroke Cerebrovasc Dis;
30(7): 105814, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33915390
12.
Sex Differences in Management and Outcomes of Cardioembolic Stroke: Post HOC Analyses of the RELAXED Study.
J Stroke Cerebrovasc Dis;
30(4): 105613, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33529924
13.
Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Sourceã- Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.
Circ J;
84(12): 2286-2295, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33132228
14.
Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study.
Heart Vessels;
35(2): 170-176, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446462
15.
Dabigatran for Japanese Patients with Atrial Fibrillation and Prior Stroke: A Subgroup Analysis of the J-Dabigatran Surveillance Program.
J Stroke Cerebrovasc Dis;
29(5): 104717, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32113736
16.
Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
J Stroke Cerebrovasc Dis;
29(8): 104936, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32689594
17.
Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin.
Stroke;
50(6): 1586-1589, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035902
18.
One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke.
N Engl J Med;
374(16): 1533-42, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27096581
19.
Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke.
Circ J;
83(6): 1385-1393, 2019 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31006731
20.
Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation : Sub-analysis of the EXPAND Study.
Heart Vessels;
34(1): 141-150, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29980835